Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

(2022) Christopher JL Murray et al.   LANCET

Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study

(2022) Elita Jauneikaite et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Short- and long-term mortality in patients with urosepsis caused by Escherichia coli susceptible and resistant to 3rd generation cephalosporins

(2022) Milena Tocut et al.   BMC INFECTIOUS DISEASES

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

(2021) Laura Evans et al.   INTENSIVE CARE MEDICINE

Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis

(2020) Parichehr Shamsrizi et al.   BMJ Open

Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review

(2020) Marc Bonten et al.   CLINICAL INFECTIOUS DISEASES

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

(2020) V de Lastours et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk factors of community-onset extended-spectrum β-lactamase Escherichia coli and Klebsiella pneumoniae bacteraemia: an 11-year population-based case-control-control study in Denmark

(2020) Rasmus Richelsen et al.   CLINICAL MICROBIOLOGY AND INFECTION

EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories

(2020) Anna Åkerlund et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark

(2020) Rasmus Richelsen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Hematologic Malignancy: A Retrospective Study from Central South China

(2020) Ting Liang et al.   Microbial Drug Resistance

Clinical outcomes and prognostic factors in bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a meta-analysis

(2020) Ai-Min Jiang et al.   Annals of Clinical Microbiology and Antimicrobials

Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis

(2020) M. C. MacKinnon et al.   Antimicrobial Resistance and Infection Control

A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase ESBL-producing Escherichia coli bloodstream infections

(2019) Tingting Xiao et al.   Journal of Global Antimicrobial Resistance

Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan

(2019) Wu-Pu Lin et al.   BMC INFECTIOUS DISEASES

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

(2019) Daniel J. Diekema et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections

(2019) Evelina Tacconelli et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance

(2019) Gemma Martinez-Nadal et al.   CLINICAL INFECTIOUS DISEASES

The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study

(2019) Nichola R. Naylor et al.   PLoS One

Temporal dynamics and risk factors for bloodstream infection with extended-spectrum β-lactamase-producing bacteria in previously colonized individuals: National population-based cohort study

(2018) Joakim Isendahl et al.   CLINICAL INFECTIOUS DISEASES

Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases

(2018) J. Rello et al.   CLINICAL MICROBIOLOGY AND INFECTION

Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records

(2018) Karina-Doris Vihta et al.   LANCET INFECTIOUS DISEASES

A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: how long is too long?

(2018) Thomas P. Lodise et al.   BMC INFECTIOUS DISEASES

Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems

(2017) E.-J. Joo et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae

(2017) Zaira Raquel Palacios-Baena et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype

(2016) Christian Sakellariou et al.   PLoS One

Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England

(2015) J.K. Abernethy et al.   CLINICAL MICROBIOLOGY AND INFECTION

The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae

(2015) Amy J. Mathers et al.   CLINICAL MICROBIOLOGY REVIEWS

Marked increase in incidence for bloodstream infections due to Escherichia coli, a side effect of previous antibiotic therapy in the elderly

(2015) Nathalie L. van der Mee-Marquet et al.   Frontiers in Microbiology

Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients – Review of the literature from a clinical perspective

(2014) Lena M. Biehl et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection

(2014) Rasmus Leistner et al.   Infection and Drug Resistance

Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer

(2013) Young Eun Ha et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis

(2012) Wouter C. Rottier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients

(2011) Sandra K Thygesen et al.   BMC Medical Research Methodology

Host Factors and Portal of Entry Outweigh Bacterial Determinants To Predict the Severity of Escherichia coli Bacteremia

(2010) A. Lefort et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and Prognosis

(2009) Jesús Rodríguez‐Baño et al.   CLINICAL INFECTIOUS DISEASES

Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region

(2008) K.B. Laupland et al.   CLINICAL MICROBIOLOGY AND INFECTION

Redefining extended-spectrum  -lactamases: balancing science and clinical need

(2008) C. G. Giske et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY